
E-cigarettes: a hazy area for dry eye research
The Tear Film and Ocular Surface Society Lifestyle Workshop emphasised the need to identify modifiable risk factors to develop effective prevention strategies for dry eye disease (DED)1. Among these f

The Tear Film and Ocular Surface Society Lifestyle Workshop emphasised the need to identify modifiable risk factors to develop effective prevention strategies for dry eye disease (DED)1. Among these f

The Royal Australian and New Zealand College of Ophthalmologists’ (RANZCO) Māori and Pasifika Eye Health Committee (MPEHC) is holding a mentoring hui on 14 September to highlight the specialty to Māor

A previously healthy young female was referred with a four-week history of blurred central vision and headaches after an overseas trip.

Glaucoma therapy-related ocular surface disease is common, requiring careful management and treatment options consideration.

Topical ivermectin 1.0% cream in the treatment of ocular demodicosisMartin Smith et al.Cont Lens Anterior Eye. 2024 Feb;47(1):102099 Review: This retrospective, single-centre study aimed to assess t

Initially scheduled to be available in June 2024, Aspen Pharmacare’s Eikance 0.01% atropine drops are now available to prescribers in New Zealand.

When it comes to researching in dry eye, everyone knows I’m the first to tell prospective researchers that ‘the sky’s the limit’. Well, it turns out this might be somewhat of an underestimation! Thank

My journey with Irlen syndrome is a testament to the importance of awareness and accurate diagnosis of this often-overlooked condition, writes Samantha Fleming

A pterygium is a benign, triangular, fibrovascular growth extending from the bulbar conjunctiva over the limbus and onto the cornea (Fig 1)¹. Pterygia are common, with world prevalence reported as 12% in a systematic review in 2018². A pterygium is an acquired proliferative disorder (rather than a d

Age-related macular degeneration (AMD) is a progressive blinding disease affecting the central retina and is a leading cause of vision loss globally. It is estimated to affect close to 9% of the worldwide population, which is expected to total 288 million patients by 20401. Unsurprisingly, numerous

The eighth Glaucoma New Zealand (GNZ) Symposium attracted a full crowd of ophthalmologists, optometrists and nurses keen to learn.

Myopia management has fascinated me since my university days. So, after I graduated, I set up New Zealand’s first myopia management clinic in Hamilton’s Rose Optometry. Back in 2009 that was considered pretty unusual, as myopia management was not as widely understood in the profession and people had